hydrochlorothiazide has been researched along with glucose, (beta-d)-isomer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Zeeuw, D; Lambers Heerspink, HJ; Leslie, B; List, J; Wie, L | 1 |
Devineni, D; Polidori, D; Rusch, S; Vaccaro, N; Wajs, E | 1 |
Broedl, UC; Heise, T; Macha, S; Mattheus, M; Woerle, HJ | 1 |
Biancalana, E; Bruno, RM; Dardano, A; Ghiadoni, L; Giannini, L; Parolini, F; Rossi, C; Seghieri, M; Solini, A; Taddei, S | 1 |
4 trial(s) available for hydrochlorothiazide and glucose, (beta-d)-isomer
Article | Year |
---|---|
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Humans; Hydrochlorothiazide; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Weight Loss | 2013 |
Effects of hydrochlorothiazide on the pharmacokinetics, pharmacodynamics, and tolerability of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in healthy participants.
Topics: Adolescent; Adult; Blood; Canagliflozin; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucosides; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Urine; Young Adult | 2014 |
Assessing pharmacokinetic interactions between the sodium glucose cotransporter 2 inhibitor empagliflozin and hydrochlorothiazide or torasemide in patients with type 2 diabetes mellitus: a randomized, open-label, crossover study.
Topics: Benzhydryl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Interactions; Female; Glucosides; Humans; Hydrochlorothiazide; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Sulfonamides; Therapeutic Equivalency; Torsemide | 2015 |
The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature.
Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Epigenesis, Genetic; Female; Glomerular Filtration Rate; Glucosides; Hospitals, University; Humans; Hydrochlorothiazide; Hypertension; Italy; Male; MicroRNAs; Middle Aged; Prognosis; Renal Circulation; Sodium-Glucose Transporter 2 Inhibitors; Statistics, Nonparametric; Treatment Outcome; Up-Regulation | 2019 |